Skip to main content

Laura Lovett

By Laura Lovett | 03:44 pm | April 04, 2022
This new round brings the company's total funding to $15.7 million. 
By Laura Lovett | 02:53 pm | April 04, 2022
The partnership, which includes Anthem, Biogen, Eli Lilly, Evidation, Janssen and Merck, gives payers guidance for including digital endpoints in reimbursement for new drugs.
By Laura Lovett | 03:38 pm | April 01, 2022
The new tool lets clinicians input a patient's name, pronouns and gender identity. 
By Laura Lovett | 02:24 pm | April 01, 2022
This new infusion of cash brings the company's total raise to $10 million. 
By Laura Lovett | 04:36 pm | March 31, 2022
The partnership will give Hims & Hers clinicians the ability to link California patients to Carbon services. 
By Laura Lovett | 12:54 pm | March 31, 2022
A new article in Nature outlines how smart toilets could help individuals determine their COVID-19 status and help public health organizations. 
By Laura Lovett | 10:29 am | March 31, 2022
The company plans to use the capital infusion to grow its teams across the board. 
By Laura Lovett | 03:44 pm | March 30, 2022
Others receiving capital infusions include Altoida, which adds $14 million to its Series A round, and Zephyr AI, which rakes in $18.5 million. 
By Laura Lovett | 12:53 pm | March 30, 2022
This M&A will expand Linus Health's capabilities into the physical-function space. 
By Laura Lovett | 12:00 pm | March 30, 2022
Solera will offer Oshi Health and Vivante Health on its digital health marketplace.